Literature DB >> 7608647

Platelet-activating factor: a mediator for clinicians.

T A Imaizumi1, D M Stafforini, Y Yamada, T M McIntyre, S M Prescott, G A Zimmerman.   

Abstract

Mesh：

Substances：

Year:  1995        PMID： 7608647     DOI： 10.1111/j.1365-2796.1995.tb00894.x

Source DB:  PubMed          Journal:  J Intern Med        ISSN： 0954-6820            Impact factor:   8.989


× No keyword cloud information.
  21 in total

Review 1.  The endothelium: physiological functions and role in microcirculatory failure during severe sepsis.

Authors:  H Ait-Oufella; E Maury; S Lehoux; B Guidet; G Offenstadt
Journal:  Intensive Care Med       Date:  2010-05-05       Impact factor: 17.440

2.  Role of cytokines and their inhibitors in acute pancreatitis.

Authors:  A Kingsnorth
Journal:  Gut       Date:  1997-01       Impact factor: 23.059

Review 3.  Optimizing the diagnosis of food allergy.

Authors:  Jacob D Kattan; Scott H Sicherer
Journal:  Immunol Allergy Clin North Am       Date:  2014-11-21       Impact factor: 3.479

4.  Platelet-activating Factor Mediates Endotoxin Tolerance by Regulating Indoleamine 2,3-Dioxygenase-dependent Expression of the Suppressor of Cytokine Signaling 3.

Authors:  Kyung Tae Noh; In Duk Jung; Gil Sun Cha; Myung-Kwan Han; Yeong-Min Park
Journal:  J Biol Chem       Date:  2017-01-11       Impact factor: 5.157

5.  Modulation of inflammatory platelet-activating factor (PAF) receptor by the acyl analogue of PAF.

Authors:  Vyala Hanumanthareddy Chaithra; Shancy Petsel Jacob; Chikkamenahalli Lakshminarayana Lakshmikanth; Mosale Seetharam Sumanth; Kandahalli Venkataranganayaka Abhilasha; Chu-Huang Chen; Anita Thyagarajan; Ravi P Sahu; Jeffery Bryant Travers; Thomas M McIntyre; Kempaiah Kemparaju; Gopal Kedihithlu Marathe
Journal:  J Lipid Res       Date:  2018-08-23       Impact factor: 5.922

6.  Lysophosphatidic acid, alkylglycerophosphate and alkylacetylglycerophosphate increase the neuronal nuclear acetylation of 1-acyl lysophosphatidyl choline by inhibition of lysophospholipase.

Authors:  R R Baker; H Y Chang
Journal:  Mol Cell Biochem       Date:  1999-08       Impact factor: 3.396

7.  Attenuation of folic acid-induced renal inflammatory injury in platelet-activating factor receptor-deficient mice.

Authors:  Kent Doi; Koji Okamoto; Kousuke Negishi; Yoshifumi Suzuki; Akihide Nakao; Toshiro Fujita; Akiko Toda; Takehiko Yokomizo; Yoshihiro Kita; Yasuyuki Kihara; Satoshi Ishii; Takao Shimizu; Eisei Noiri
Journal:  Am J Pathol       Date:  2006-05       Impact factor: 4.307

8.  Neuroprotection during cardiac surgery: a randomised trial of a platelet activating factor antagonist.

Authors:  D P Taggart; S M Browne; D T Wade; P W Halligan
Journal:  Heart       Date:  2003-08       Impact factor: 5.994

9.  Effect of a platelet-activating factor (PAF) receptor antagonist on hyperacute xenograft rejection; evaluation in a pig kidney-human blood xenoperfusion model.

Authors:  J M Cruzado; J Torras; M Riera; N Lloberas; I Herrero; E Condom; J Martorell; J Alsina; J M Grinyó
Journal:  Clin Exp Immunol       Date:  1998-07       Impact factor: 4.330

10.  The novel role of platelet-activating factor in protecting mice against lipopolysaccharide-induced endotoxic shock.

Authors:  Young-Il Jeong; In Duk Jung; Chang-Min Lee; Jeong Hyun Chang; Sung Hak Chun; Kyung Tae Noh; Soo Kyung Jeong; Yong Kyoo Shin; Won Suk Lee; Mi Sun Kang; Sang-Yull Lee; Jae-Dong Lee; Yeong-Min Park
Journal:  PLoS One       Date:  2009-08-04       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.